GSK spinoff Haleon has no deals on immediate horizon. By Natalie Grover and Maggie Fick. March 2, 2023 4:45 PM UTC Updated March 2, 2023 ... vitamins and oral care products. ...

GSK's consumer health spinout Haleon started trading on the London Stock Exchange this morning, making its debut with a price of 330 pence and a market valuation of around £31 billion ($37 billion).

GSK has agreed to pay up to $2.2 billion to settle most lawsuits in US state courts claiming that a discontinued version of the heartburn drug Zantac caused cancer, the company announced on Wednesday.

GSK split will help deal with ‘perennial underperformance’, ... Haleon, a joint venture with Pfizer that owns brands including Sensodyne toothpaste and Centrum vitamins, ...

T he story of GSK is one of reinvention, CEO Emma Walmsley said at the STAT Summit in Boston on Thursday. Having shed its consumer division, the British drug giant is writing a new chapter as a ...